RxDoctor Payments Data

Akanksha Agrawal, MD

Advanced Heart Failure and Transplant Cardiology · Orlando, FLNPI 1730563628

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,407 of the $4,767 with a category attached, or 71.5%. Abbott accounts for 60.2% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2023 at $1,981 and has fallen 76.4% since, to $467 in 2025. That places this record below the midpoint for advanced heart failure and transplant cardiology clinicians in FL, where the typical reported total is $7,029.

$4,767in general payments, 2019–2025

Across 79 payments — averaging $60.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$3K
  • Merit Medical Systems Inc$350
  • Cvrx, Inc.$254
  • Asahi Intecc USA, Inc.$244
  • Kestra Medical Technology Services, Inc.$196
  • Boston Scientific$147
  • plus $707 from 12 others

What the payments were for

  • Consulting fees$3507%
  • Travel & lodging$85518%
  • Food & beverage$3,40771%
  • Education$1563%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,767 in reported general payments places this provider in the 35th percentile of 48 advanced heart failure and transplant cardiology providers in Florida.

See all advanced heart failure and transplant cardiology providers in Florida

Medicare billing

Part B allowed, 2024
$116,588
Medicare patients
200
Services billed
990

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin50$57,550
EntrestoSacubitril/Valsartan28$33,543
Sirolimus33$21,281
Tacrolimus37$6,706
Mycophenolate Mofetil35$5,407
Mycophenolic AcidMycophenolate Sodium20$5,205
Bumetanide38$952
Losartan Potassium50$743
Rosuvastatin Calcium31$588
Carvedilol52$469
Pravastatin Sodium29$434
Spironolactone54$334
Gabapentin19$302
Amlodipine Besylate34$293
Atorvastatin Calcium25$292

Paid to pharmacies, not to this prescriber.

Other advanced heart failure and transplant cardiology in Orlando

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →